Racial disparities in risk of second primary cancers in endometrial cancer patients: Analysis of SEER Data
- PMID: 21528021
- PMCID: PMC3081714
- DOI: 10.1097/IGC.0b013e318206a098
Racial disparities in risk of second primary cancers in endometrial cancer patients: Analysis of SEER Data
Abstract
INTRODUCTION: Endometrial cancer (EC) is the most common gynecologic cancer in the United States. Racial disparities in the incidence and mortality of this cancer are apparent; black women are less likely to develop this malignancy, and yet are more likely to die when diagnosed. Racial differences of second primary cancer (SPC) have not been examined and are the goal of this study. METHODS: Using the National Cancer Institute's Surveillance, Epidemiology, and End Results database, SPC risk in white and black EC cases was compared to the general population and to women with other primary cancers. Standardized incidence ratios (SIRs) of SPC (overall and by tumor site) with 95% confidence intervals were calculated. Poisson regression was used to estimate the race-specific risk of SPC in EC cases treated with radiotherapy vs. non-irradiated cases. RESULTS: The analysis included 11,047 EC cases diagnosed between 1973 and 2007 that developed a SPC. Overall risk of SPC in white EC cases was significantly lower than the general population (SIR=0.85, 95% CI: 0.84, 0.87), but significantly higher in black EC cases (SIR=1.19, 95% CI: 1.08, 1.31). White EC cases treated with radiotherapy were more likely to develop SPC compared to non-irradiated cases (IRR=1.18, 95% CI: 1.14, 1.23). CONCLUSIONS: This is the first analysis of race-specific SPC risk in EC cases and it suggests differences between white and black cases. Although exploratory, these data provide important clues about the etiology of SPC in patients with EC. This analysis also highlights the need for careful monitoring following diagnosis and treatment of EC.
Figures


Similar articles
-
The Black Book of Psychotropic Dosing and Monitoring.Psychopharmacol Bull. 2024 Jul 8;54(3):8-59. Psychopharmacol Bull. 2024. PMID: 38993656 Free PMC article. Review.
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320. Health Technol Assess. 2001. PMID: 12065068
-
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280. Health Technol Assess. 2008. PMID: 18547499
-
Electronic cigarettes for smoking cessation.Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD010216. doi: 10.1002/14651858.CD010216.pub7. Cochrane Database Syst Rev. 2022. Update in: Cochrane Database Syst Rev. 2024 Jan 8;1:CD010216. doi: 10.1002/14651858.CD010216.pub8. PMID: 36384212 Free PMC article. Updated.
-
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23. Clin Orthop Relat Res. 2024. PMID: 39051924
Cited by
-
Survival for endometrial cancer as a second primary malignancy.Cancer Med. 2022 Mar;11(6):1490-1501. doi: 10.1002/cam4.4554. Epub 2022 Jan 30. Cancer Med. 2022. PMID: 35098701 Free PMC article.
-
The bidirectional association among female hormone-related cancers: breast, ovary, and uterine corpus.Cancer Med. 2018 Jun;7(6):2299-2306. doi: 10.1002/cam4.1473. Epub 2018 Apr 16. Cancer Med. 2018. PMID: 29659167 Free PMC article.
-
Increased risk of second primary malignancies among endometrial cancer survivors receiving surgery alone: A population-based analysis.Cancer Med. 2021 Oct;10(19):6845-6854. doi: 10.1002/cam4.3861. Epub 2021 Sep 15. Cancer Med. 2021. PMID: 34523816 Free PMC article.
-
Peptide ancestry informative markers in uterine neoplasms from women of European, African, and Asian ancestry.iScience. 2021 Dec 23;25(1):103665. doi: 10.1016/j.isci.2021.103665. eCollection 2022 Jan 21. iScience. 2021. PMID: 35036865 Free PMC article.
-
Increased risk of second primary malignancies following uterine cancer: a population-based study in Taiwan over a 30-year period.BMC Cancer. 2015 May 11;15:393. doi: 10.1186/s12885-015-1426-3. BMC Cancer. 2015. PMID: 25957789 Free PMC article.
References
-
- Ueda SM, Kapp DS, Cheung MK, et al. Trends in demographic and clinical characteristics in women diagnosed with corpus cancer and their potential impact on the increasing number of deaths. Am J Obstet Gynecol. 2008;198:218 e1–6. - PubMed
-
- Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009. CA Cancer J Clin. 2009;59:225–49. - PubMed
-
- Wright JD, Fiorelli J, Schiff PB, et al. Racial disparities for uterine corpus tumors: changes in clinical characteristics and treatment over time. Cancer. 2009;115:1276–85. - PubMed
-
- Sherman ME, Devesa SS. Analysis of racial differences in incidence, survival, and mortality for malignant tumors of the uterine corpus. Cancer. 2003;98:176–86. - PubMed
-
- Liu JR, Conaway M, Rodriguez GC, et al. Relationship between race and interval to treatment in endometrial cancer. Obstet Gynecol. 1995;86:486–90. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources